Biological alternatives to insulin therapy

Experimental and Clinical Endocrinology and Diabetes

Volumn 107, Issue SUPPL. 2, 1999, Pages

  Bretzel, Reinhard G ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Allo autoimmunity; End stage renal disease; Immunosuppression; Immunotolerance; Islet transplantation; Kidney transplantation; Pancreas transplantation

Indexed keywords

EID: 0002920550     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0029-1212149     Document Type: Article

References (12)

1. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med (1993); 329: 977-986
2. Wang PH, Lau J, Chalmers TC. Meta-analysis of effects of intensive blood-glucose control on late complications of type-1 diabetes. Lancet 341 (1993); 1306-1309
3. The Diabetes Control and Complications Trial Research Group. Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes (1997); 46: 271-286
4. Sutherland DE, Gores PF, Farney AC, Wahoff DC, Matas AJ, Dunn DL, Gruessner RW, Najarian JS. Evolution of kidney, pancreas, and islet transplantation for patients with diabetes at the University of Minnesota. Am J Surg 166 (1993); 456-491
5. Bretzel RG, Browatzki CC, Schultz A, Brandhorst H, Klitscher D, Bollen CC, Raptis G, Friemann S, Ernst W, Rau WS, Hering BJ. Clinical islet transplantation in diabetes mellitus - report of the Islet Transplant Registry and the Giessen Center experience. Diabetes Stoffw (1993); 2: 378-390
6. American Diabetes Association. Pancreas transplantation for patients with diabetes mellitus. Diab Care (1992); 15: 1668-1672
7. Bland BJ. International Pancreas Transplant Registry (IPTR) - Annual Report for 1997. IPTR Newsletter (1998); 10: 4-14
8. Secchi A, Di Carlo V, Pozza G. Pancreas and islet transplantation: current progresses, problems and perspectives. Horm Metab Res (1997); 29: 1-8
9. Gross CR, Zehrer CL. Health-related quality of life outcomes of pancreas transplant recipients. Clin Transplant (1992); 6: 165-171
10. Hering BJ, Brendel MD, Schultz AO, Schultz B, Bretzel RG. Adult islet allografts in patients with type-1 diabetes. ITR Newsletter (1996); 6: 9-15
11. Bretzel RG, Brandhorst D, Brandhorst H, Eckhard M, Ernst W, Friemann S, Rau W, Weimar B, Rauber K, Hering BJ, Brendel MD. Improved survival of intraportal pancreatic islet cell allografts in patients with type-1 diabetes mellitus by refined peritransplant management. J Mol Med (1999); 77: 140-143
12. Meyer C, Hering BJ, Grossmann R, Brandhorst H, Brandhorst D, Gerich J, Federlin K, Bretzel RG. Improved glucose counterregulation and autonomic symptoms after intraportal islet transplants alone in patients with long-standing type I diabetes mellitus. Transplantation (1998); 66: 233-240